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Introduction 
Cartilage tissue engineering adapted into clinical 
applications such as autologous chondrocytes 
implantation (ACI) (Brittberg et al, 1993) and the use of 
mesencyhmal stem cells (MSCs) has emerged as a 
promising new therapy for the treatment of damaged 
cartilage. However, it has been found that the success of 
this therapy relies on the development of a suitable 
scaffold to provide a template for cell and tissue growth. 
Scaffolds not only provide the necessary biomechanical 
strength to withstand joint compressive loading but 
important to convert the implanted cell-scaffold 
construct into native cartilage. In an attempt to develop 
an ideal scaffold or cell carrier, we have synthesised a 
novel porous three-dimensional composite scaffold 
based on polyvinyl alcohol (PVA) and N,O-
carboxymethylate chitosan (NOCC). Incorporating 
NOCC with PVA is done to obtain the excellent weight-
bearing properties of PVA (Stammen et al, 2001) while 
possessing the biodegradability ability of NOCC. Apart 
from being both biocompatible and biodegradable, 
chitosan itself has structural similarity to 
glycosaminoglycans (GAGs) (Griffon et al, 2006) and 
hyaluronic acid, which are significant components in 
articular cartilage extracellular matrix (ECM). In the 
present study, our newly-synthesised PVA-NOCC 
composite was characterised in vitro to evaluate its 
potential as a scaffold for future application in cartilage 
tissue engineering.   
 
Materials and Methods  
PVA-117 (Mw=74,000g/mol) was obtained from 
Kuraray Co. Ltd, Japan whilst NOCC was obtained 
from Standard and Industrial Research Institute 
(SIRIM), Malaysia. PVA and NOCC were mixed and 
the polymer solutions casted into cylindrical moulds. 
The resultant PVA-NOCC blend was then sterilised and 
physically cross-linked by irradiation at room 
temperature, following by frozen at -80°C prior to 
lyophilisation. The porous composite scaffold was cut 
into discs (3mm height/5mm diameter). The structure of 
the scaffold was examined using a scanning electron 
microscope (SEM). Pore size was measured and 
analysed. Chondrocytes derived from articular cartilage 
of New Zealand White rabbits were then seeded at a 
density of 5X10
6 
on each pre-wetted scaffold, cultured 
up to 2 and 4 weeks prior to in vitro characterisation. 
Histological (Safranin-O, immunohistochemistry and 
DAPI staining), electron microscopy (TEM/SEM) and 
biochemical analyses (DMMB-GAG and collagen 
assay) were performed to assess cell-matrix morphology 
and response. 
 
Results and Discussion  
SEM analysis demonstrated that PVA-NOCC scaffold 
possessed an interconnecting porous structure with pore 
sizes ranging between 1-200µm. Within 4 weeks, 
chondrocytes acquired predominantly spherical shapes 
(Albert et al, 1983) and reached confluence on the 
scaffolds. The cultured chondrocytes adhered 
extensively to the porous scaffold surfaces and also 
penetrated interconnecting pores, formed dense colonies 
and retained their in vivo morphology. Cells were 
surrounded by distinct fibrillar ECM networks 
consisting of collagen fibers and proteoglycans. DAPI-
stained nuclei were noted to be localised within the 
scaffold. TEM analysis further revealed that 
chondrocytes within the construct appeared as healthy 
and active cartilage cells exhibited normal ultrastructure 
features, possessed large nuclei with mitochondria 
distributed intercellularly and abundant ECM secreted 
by chondrocytes within PVA-NOCC. Histology study 
confirmed the presence of ECM consisting of 
proteoglycans and type II collagen. The amount of S-
GAG and type II collagen was significantly higher in 
PVA-NOCC as compared to PVA in both 2- and 4-
week culture. The results indicated that PVA-NOCC is 
superior to PVA alone. PVA-NOCC composite scaffold 
showed better cell adhesion, proliferation, migration 
and tissue-integration properties. This porous 3-D 
composite scaffold also possessed sufficient mechanical 
properties and demonstrated viscoelastic properties 
which mimic native cartilage in our previous study (S-Y 
Lee et al, 2009). 
 
Conclusions 
The data obtained in this study clearly demonstrates the 
ability of chondrocytes to maintain phenotypic 
expression as well as synthesis ECM on our porous 
PVA-NOCC scaffold. Thus, porous PVA-NOCC is 
potentially suitable to be used as a scaffold for tissue 
engineered cartilage in the treatment of articular 
cartilage defects.  
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